
Human Longevity, Inc. (HLI) is a precision medicine company focused on extending healthy human life through data-driven, personalized healthcare. They utilize comprehensive assessments, including whole genome sequencing and advanced diagnostics like Whole Body MRI, to detect potential health risks at their earliest stages, even before symptoms appear. HLI aims to transform the practice of medicine by generating personalized health insights from the world's largest database of whole genome, phenotype, and clinical data. Their approach integrates cutting-edge science with a patient-centered care model, offering services like Executive Health and longevity care.

Human Longevity, Inc. (HLI) is a precision medicine company focused on extending healthy human life through data-driven, personalized healthcare. They utilize comprehensive assessments, including whole genome sequencing and advanced diagnostics like Whole Body MRI, to detect potential health risks at their earliest stages, even before symptoms appear. HLI aims to transform the practice of medicine by generating personalized health insights from the world's largest database of whole genome, phenotype, and clinical data. Their approach integrates cutting-edge science with a patient-centered care model, offering services like Executive Health and longevity care.
Founded: 2013
Headquarters: San Diego, California
Core offering: Precision medicine combining whole-genome sequencing, advanced imaging, and ML for longevity-focused clinical assessments
Employee count: 80
Total funding (reported): USD 369,800,000
Early detection, preventive/precision medicine, longevity care using genomic and phenotypic data.
2013
Precision medicine / Genomics / Health diagnostics
Most recent round reported as Series B; lead investor identified.
“Backed by multiple investors (reported as 15); recent/lead investor TVM Capital Healthcare”